On March 19, as shown in Tianyancha, Aier Eye Hospital Group Co., Ltd. published an invention patent entitled "A risk assessment device for myopia". The application date is December 2020, and the publication number is CN112530596A.
The patent abstract shows that the present invention discloses a myopia risk assessment device, including an acquisition device and a processing device. The acquisition device acquires parameter data of myopia parameters at multiple positions within a predetermined area of the myopia risk assessment subject's retina. The processing device is based on the various positions' parameter data obtain representative data of myopia parameters in the predetermined area of the assessment object's retina and obtain the risk result according to the obtained representative data and the myopia occurrence risk model.
The invention obtains the myopia parameter's representative data by obtaining the parameter data of the myopia parameter in the preset area of the retina. It then uses the myopia occurrence risk model to get the myopia risk result of the myopia risk assessment object, which applies to various visual states' objects, with good applicability. It can assess the risk of myopia accurately.
